Osteoradionecrosis of the jaws (ORNJ) is a severe complication of radiotherapy for head and neck cancer, with limited data on prognostic factors. This study aimed to identify risk factors associated with wound healing prognosis in ORNJ patients. A retrospective cohort study was conducted following STROBE guidelines, including 106 ORNJ patients treated at a tertiary hospital between 2005 and 2020. Patients were divided into normal wound healing (NH, within 7–10 days postoperatively) and delayed wound healing (DH, ≥11 days postoperatively) groups. Univariate analysis, multivariate Logistic regression, and Cox proportional hazards models were used to identify prognostic factors. The median follow-up was 38.6 months. Univariate analysis showed DH patients had significantly higher baseline PIV (median: 490.1 vs 437.8) and SII (median: 775.6 vs 732.2) than NH patients (all p < 0.001). Multivariate logistic regression showed that diabetes mellitus (OR = 9.687, p = 0.010), Charlson comorbidity index (CCI, OR = 10.004, p < 0.001), primary tumor site (OR = 10.384, p = 0.006), T stage (OR = 27.340, p < 0.001), ORNJ grade at diagnosis (OR = 4.367, p < 0.001), pan-immune-inflammatory value (PIV, OR = 1.043, p < 0.001), and systemic immune-inflammatory index (SII, OR = 1.023, p < 0.001) were independent risk factors for delayed healing. Kaplan-Meier curves showed that patients in the highest PIV tertile had significantly longer time-to-healing (median: 31.5 vs 18.3 days, Log-rank p < 0.001). PIV and SII, along with clinical factors (diabetes mellitus, CCI, T stage, ORNJ grade), are independent prognostic factors for wound healing in ORNJ patients. These findings may help clinicians optimize treatment strategies and predict outcomes. • First study to identify PIV and SII as independent prognostic factors for wound healing in ORNJ patients. • Diabetes mellitus, CCI, T stage and ORNJ grade are clinical predictors of delayed ORNJ wound healing. • Highest PIV tertile correlates with 1.7-fold longer median time-to-healing in ORNJ patients. • V58 radiation dose-volume metric is an independent predictor in ORNJ patients.
Li et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: